Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis.

Nature genetics·2025
Same author

Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML.

Blood·2025
Same author

Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein.

Nature biotechnology·2025
Same author

Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis.

Nature·2025
Same author

Lithography-Free Water Stable Conductive Polymer Nanowires.

Nano letters·2025
Same author

TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells.

Nature communications·2024

Related Experiment Video

Updated: Apr 30, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

6.8K

RNA interference screening to detect targetable molecules in hematopoietic stem cells.

Christine Karlsson1, Justyna Rak, Jonas Larsson

  • 1Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden *Christine Karlsson and Justyna Rak contributed equally to the writing of this article and are considered co-first authors.

Current Opinion in Hematology
|May 10, 2014
PubMed
Summary

RNA interference (RNAi) screening is a powerful tool for understanding hematopoietic stem cells (HSCs). This method helps identify new therapeutic targets for both normal and cancerous HSCs, advancing hematopoiesis research.

More Related Videos

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
07:01

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

830
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

11.3K

Related Experiment Videos

Last Updated: Apr 30, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

6.8K
Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
07:01

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

830
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

11.3K

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Hematopoietic stem cells (HSCs) are crucial for blood formation, but their regulatory mechanisms are not fully understood.
  • Understanding HSC regulation is key to treating blood disorders and cancers.

Purpose of the Study:

  • To review the application of RNA interference (RNAi) screening in dissecting the molecular regulation of HSCs.
  • To highlight the potential of RNAi screening for identifying novel therapeutic targets in normal and malignant hematopoiesis.

Main Methods:

  • Utilizing advances in RNA interference (RNAi) technology, including short hairpin RNA (shRNA) retroviral and lentiviral vector libraries.
  • Performing broad forward genetic screens in primary mammalian hematopoietic cells.

Main Results:

  • RNAi screens have identified novel fate determinants in murine HSCs.
  • Studies have revealed potential targets for ex-vivo expansion of human HSCs.
  • RNAi screens have uncovered tumor suppressor genes in hematopoietic neoplasms and therapeutic targets in leukemia.

Conclusions:

  • RNAi screening is a viable method for discovering molecules regulating normal and malignant HSCs.
  • This technology enhances the understanding of hematopoiesis physiology and pathophysiology.
  • RNAi holds significant promise for identifying specific therapeutic targets for clinical application.